| Brandon W Harden, MD | |
|
1000 Hawthorne Ave Ste S, Athens, GA 30606-2168 | |
| (404) 256-2593 | |
| (770) 488-9408 |
| Full Name | Brandon W Harden |
|---|---|
| Gender | Male |
| Speciality | Pediatrics - Pediatric Cardiology |
| Location | 1000 Hawthorne Ave Ste S, Athens, Georgia |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1154539385 | NPI | - | NPPES |
| 111173 | Medicaid | AL | |
| 111256 | Medicaid | AL | |
| 1154539385 | Other | AL | TRICARE SOUTH |
| 515-98963 | Other | AL | BCBS |
| 515-98918 | Other | AL | BCBS |
| 003130101A | Medicaid | GA |
| Entity Name | Hospital Authority Of Mitchell County |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1700830247 PECOS PAC ID: 6002724598 Enrollment ID: O20031117000138 |
News Archive
Results of a new study reported this week by David Moorman of the University of Massachusetts Amherst and Gary Aston-Jones of Rutgers University suggest that adjusting behavior based on previous events involves an unexpected mix of neurons working together in the brain's prefrontal cortex.
Talyst, a market leader in pharmacy automation and 340B solutions, will be exhibiting at the 2014 American Society of Health-System Pharmacists (ASHP) Summer Meeting in Las Vegas, NV.
Acorda Therapeutics, Inc. today announced the wholesale acquisition cost (WAC) for AMPYRA™ (dalfampridine) Extended Release Tablets will be $1,056 per 30-day supply (60-count pill bottle), an annual cost of $12,850. AMPYRA was approved on January 22, 2010 by the U.S. Food and Drug Administration (FDA) as a treatment to improve walking in patients with multiple sclerosis (MS). This was demonstrated by an increase in walking speed. AMPYRA is expected to be available in March 2010.
The Centers for Disease Control and Prevention (CDC) released an online storybook containing narratives from survivors, families, and friends about one of the largest scourges ever on human kind - the 1918 influenza pandemic that killed millions of people around the world.
› Verified 9 days ago
| Entity Name | John D. Archbold Memorial Hospital, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1194779702 PECOS PAC ID: 4981502622 Enrollment ID: O20031219000506 |
News Archive
Results of a new study reported this week by David Moorman of the University of Massachusetts Amherst and Gary Aston-Jones of Rutgers University suggest that adjusting behavior based on previous events involves an unexpected mix of neurons working together in the brain's prefrontal cortex.
Talyst, a market leader in pharmacy automation and 340B solutions, will be exhibiting at the 2014 American Society of Health-System Pharmacists (ASHP) Summer Meeting in Las Vegas, NV.
Acorda Therapeutics, Inc. today announced the wholesale acquisition cost (WAC) for AMPYRA™ (dalfampridine) Extended Release Tablets will be $1,056 per 30-day supply (60-count pill bottle), an annual cost of $12,850. AMPYRA was approved on January 22, 2010 by the U.S. Food and Drug Administration (FDA) as a treatment to improve walking in patients with multiple sclerosis (MS). This was demonstrated by an increase in walking speed. AMPYRA is expected to be available in March 2010.
The Centers for Disease Control and Prevention (CDC) released an online storybook containing narratives from survivors, families, and friends about one of the largest scourges ever on human kind - the 1918 influenza pandemic that killed millions of people around the world.
› Verified 9 days ago
| Entity Name | Grady General Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1013961507 PECOS PAC ID: 7618866518 Enrollment ID: O20040310001254 |
News Archive
Results of a new study reported this week by David Moorman of the University of Massachusetts Amherst and Gary Aston-Jones of Rutgers University suggest that adjusting behavior based on previous events involves an unexpected mix of neurons working together in the brain's prefrontal cortex.
Talyst, a market leader in pharmacy automation and 340B solutions, will be exhibiting at the 2014 American Society of Health-System Pharmacists (ASHP) Summer Meeting in Las Vegas, NV.
Acorda Therapeutics, Inc. today announced the wholesale acquisition cost (WAC) for AMPYRA™ (dalfampridine) Extended Release Tablets will be $1,056 per 30-day supply (60-count pill bottle), an annual cost of $12,850. AMPYRA was approved on January 22, 2010 by the U.S. Food and Drug Administration (FDA) as a treatment to improve walking in patients with multiple sclerosis (MS). This was demonstrated by an increase in walking speed. AMPYRA is expected to be available in March 2010.
The Centers for Disease Control and Prevention (CDC) released an online storybook containing narratives from survivors, families, and friends about one of the largest scourges ever on human kind - the 1918 influenza pandemic that killed millions of people around the world.
› Verified 9 days ago
| Entity Name | Brooks County Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1306890942 PECOS PAC ID: 1557279049 Enrollment ID: O20040316000884 |
News Archive
Results of a new study reported this week by David Moorman of the University of Massachusetts Amherst and Gary Aston-Jones of Rutgers University suggest that adjusting behavior based on previous events involves an unexpected mix of neurons working together in the brain's prefrontal cortex.
Talyst, a market leader in pharmacy automation and 340B solutions, will be exhibiting at the 2014 American Society of Health-System Pharmacists (ASHP) Summer Meeting in Las Vegas, NV.
Acorda Therapeutics, Inc. today announced the wholesale acquisition cost (WAC) for AMPYRA™ (dalfampridine) Extended Release Tablets will be $1,056 per 30-day supply (60-count pill bottle), an annual cost of $12,850. AMPYRA was approved on January 22, 2010 by the U.S. Food and Drug Administration (FDA) as a treatment to improve walking in patients with multiple sclerosis (MS). This was demonstrated by an increase in walking speed. AMPYRA is expected to be available in March 2010.
The Centers for Disease Control and Prevention (CDC) released an online storybook containing narratives from survivors, families, and friends about one of the largest scourges ever on human kind - the 1918 influenza pandemic that killed millions of people around the world.
› Verified 9 days ago
| Entity Name | Children's Healthcare Of Atlanta Cardiology Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235148727 PECOS PAC ID: 6901888395 Enrollment ID: O20040601000805 |
News Archive
Results of a new study reported this week by David Moorman of the University of Massachusetts Amherst and Gary Aston-Jones of Rutgers University suggest that adjusting behavior based on previous events involves an unexpected mix of neurons working together in the brain's prefrontal cortex.
Talyst, a market leader in pharmacy automation and 340B solutions, will be exhibiting at the 2014 American Society of Health-System Pharmacists (ASHP) Summer Meeting in Las Vegas, NV.
Acorda Therapeutics, Inc. today announced the wholesale acquisition cost (WAC) for AMPYRA™ (dalfampridine) Extended Release Tablets will be $1,056 per 30-day supply (60-count pill bottle), an annual cost of $12,850. AMPYRA was approved on January 22, 2010 by the U.S. Food and Drug Administration (FDA) as a treatment to improve walking in patients with multiple sclerosis (MS). This was demonstrated by an increase in walking speed. AMPYRA is expected to be available in March 2010.
The Centers for Disease Control and Prevention (CDC) released an online storybook containing narratives from survivors, families, and friends about one of the largest scourges ever on human kind - the 1918 influenza pandemic that killed millions of people around the world.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Brandon W Harden, MD 2835 Brandywine Rd, Suite 300, Atlanta, GA 30341-5510 Ph: (404) 256-2593 | Brandon W Harden, MD 1000 Hawthorne Ave Ste S, Athens, GA 30606-2168 Ph: (404) 256-2593 |
News Archive
Results of a new study reported this week by David Moorman of the University of Massachusetts Amherst and Gary Aston-Jones of Rutgers University suggest that adjusting behavior based on previous events involves an unexpected mix of neurons working together in the brain's prefrontal cortex.
Talyst, a market leader in pharmacy automation and 340B solutions, will be exhibiting at the 2014 American Society of Health-System Pharmacists (ASHP) Summer Meeting in Las Vegas, NV.
Acorda Therapeutics, Inc. today announced the wholesale acquisition cost (WAC) for AMPYRA™ (dalfampridine) Extended Release Tablets will be $1,056 per 30-day supply (60-count pill bottle), an annual cost of $12,850. AMPYRA was approved on January 22, 2010 by the U.S. Food and Drug Administration (FDA) as a treatment to improve walking in patients with multiple sclerosis (MS). This was demonstrated by an increase in walking speed. AMPYRA is expected to be available in March 2010.
The Centers for Disease Control and Prevention (CDC) released an online storybook containing narratives from survivors, families, and friends about one of the largest scourges ever on human kind - the 1918 influenza pandemic that killed millions of people around the world.
› Verified 9 days ago
James Nicholas Frisk, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 125 Telfair Pl, Athens, GA 30606 Phone: 706-548-2454 | |
Victor Morales, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1230 Baxter St, Athens, GA 30606 Phone: 706-389-3000 Fax: 706-389-3839 | |
Charles F Potter, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 1230 Baxter St, Athens, GA 30606 Phone: 706-769-0005 | |
Dr. Ashley Marie Bohn, DO Pediatrics Medicare: Medicare Enrolled Practice Location: 1500 Oglethorpe Ave Ste 600ef, Athens, GA 30606 Phone: 706-613-5980 | |
Nancy C Hendrix, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 225 Hawthorne Park, Athens, GA 30606 Phone: 706-613-6136 Fax: 706-353-1604 | |
Dr. Eugene Brannon Morris Iii, MD Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 1086 1/2 Baxter St, Athens, GA 30606 Phone: 706-353-0606 Fax: 706-353-0798 | |
Rajiv K Setia, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 225 Hawthorne Park, Athens, GA 30606 Phone: 706-613-6136 Fax: 706-543-0706 |